Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (GIS) global food company with $19.9B revenue; Cheerios, Betty Crocker, Pillsbury, Blue Buffalo pet food competing with Kellanova and Nestlé while managing GLP-1 drug volume impact.
General Mills is a Minneapolis-based global food company producing packaged foods across breakfast cereals, convenient meals, snacks, baking products, yogurt, and pet food through iconic consumer brands including Cheerios, Wheaties, Betty Crocker, Pillsbury, Yoplait, Nature Valley, Häagen-Dazs, and Blue Buffalo (pet food). Listed on NYSE (NYSE: GIS), General Mills generated approximately $19.9 billion in net sales in fiscal year 2024 (ending May 2024) and employs approximately 33,000 people globally, distributing products in 100+ countries.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.